No Data
No Data
Bullish Wednesday For Marijuana Stocks - Cara Therapeutics, MPX International Among Top Gainers
Why OrganiGram (OGI) Is Among the Best Pot Stocks to Invest in According to Analysts?
Cannabis Sector Limps Into 2025 Because 'the Gold Rush Is Over'
CCORF Maintains OrganiGram(OGI.US) With Buy Rating, Maintains Target Price $2.18
Organigram Reports Q4 Revenue C$44.7M Vs. C$36.7M Last Year
Haywood Maintains OrganiGram(OGI.US) With Buy Rating, Raises Target Price to $3